scholarly journals Application of long-interval paired-pulse transcranial magnetic stimulation to motion-sensitive visual cortex does not lead to changes in motion perception

2019 ◽  
Author(s):  
Olga Lucia Gamboa Arana ◽  
Alexandra Brito ◽  
Zachary Abzug ◽  
Tracy D’Arbeloff ◽  
Lysianne Beynel ◽  
...  

ABSTRACTThe perception of visual motion is dependent on a set of occipitotemporal regions which are readily accessible to neuromodulation. Previous studies using paired-pulse Transcranial Magnetic Stimulation (ppTMS) have provided evidence of the capacity of this type of protocols to modulate cognitive processes. To test whether such cortical modulation can be observed in the visual system, particularly during motion perception, ppTMS was applied to the occipital cortex using both scalp-based and meta-analytic targeting coordinates. In this within-subject, sham-controlled study, fifteen subjects completed two sessions in two consecutive weeks. On the first visit, subject-specific resting motor threshold (RMT) was determined and participants performed an adaptive motion discrimination task to determine individual motion sensitivity. During the second visit, subjects performed the same task with three individualized difficulty levels as two TMS pulses were delivered respectively −150 and −50 ms prior to motion stimulus onset at 120% RMT, under the logic that the cumulative inhibitory effect of these two pulses would alter motion sensitivity as measured by the individually calibrated task. The ppTMS was delivered at one of two locations: 3 cm dorsal and 5 cm lateral to inion (scalp-based coordinate), or at the site of peak activation for “motion” according to the NeuroSynth fMRI database (meta-analytic coordinate). Sham stimulation was delivered on one-third of trials and evenly between the two targets. Analyses showed no significant active-versus-sham effects of ppTMS when stimulation was delivered to the meta-analytic (p = 0.15) or scalp-based coordinates (p = 0.17), which were separated by 29 mm on average. Additionally, there was no was significant interaction between ppTMS at either location and task difficulty level (p = 0.12 and p = 0.33, respectively). These findings fail to support the hypothesis that long-interval ppTMS recruits inhibitory processes in motion-sensitive cortex, but must be considered within the limits of the current design choices.HIGHLIGHTSLong-interval paired-pulse TMS was applied to visual cortex during a motion taskThe ppTMS was delivered according to scalp and meta-analytic coordinates, as well as shamNo effects of active-versus-sham stimulation were observed on motion task performance

2020 ◽  
Vol 131 (4) ◽  
pp. e76
Author(s):  
D. Khammash ◽  
M. Simmonite ◽  
T.A. Polk ◽  
S.F. Taylor ◽  
S.K. Meehan

2006 ◽  
Vol 101 (2) ◽  
pp. 500-505 ◽  
Author(s):  
Gabrielle Todd ◽  
Stanley C. Flavel ◽  
Michael C. Ridding

Repetitive transcranial magnetic stimulation of the motor cortex (rTMS) can be used to modify motor cortical excitability in human subjects. At stimulus intensities near to or above resting motor threshold, low-frequency rTMS (∼1 Hz) decreases motor cortical excitability, whereas high-frequency rTMS (5–20 Hz) can increase excitability. We investigated the effect of 10 min of intermittent rTMS on motor cortical excitability in normal subjects at two frequencies (2 or 6 Hz). Three low intensities of stimulation (70, 80, and 90% of active motor threshold) and sham stimulation were used. The number of stimuli were matched between conditions. Motor cortical excitability was investigated by measurement of the motor-evoked potential (MEP) evoked by single magnetic stimuli in the relaxed first dorsal interosseus muscle. The intensity of the single stimuli was set to evoke baseline MEPs of ∼1 mV in amplitude. Both 2- and 6-Hz stimulation, at 80% of active motor threshold, reduced the magnitude of MEPs for ∼30 min ( P < 0.05). MEPs returned to baseline values after a weak voluntary contraction. Stimulation at 70 and 90% of active motor threshold and sham stimulation did not induce a significant group effect on MEP magnitude. However, the intersubject response to rTMS at 90% of active motor threshold was highly variable, with some subjects showing significant MEP facilitation and others inhibition. These results suggest that, at low stimulus intensities, the intensity of stimulation may be as important as frequency in determining the effect of rTMS on motor cortical excitability.


2005 ◽  
Vol 382 (3) ◽  
pp. 312-316 ◽  
Author(s):  
Roland Sparing ◽  
Nina Dambeck ◽  
Kathrin Stock ◽  
Ingo G. Meister ◽  
Dorothee Huetter ◽  
...  

2020 ◽  
Vol 730 ◽  
pp. 135022 ◽  
Author(s):  
Olga Lucia Gamboa ◽  
Alexandra Brito ◽  
Zachary Abzug ◽  
Tracy D’Arbeloff ◽  
Lysianne Beynel ◽  
...  

2021 ◽  
pp. 1-11
Author(s):  
Thyciane Mendonça ◽  
Rodrigo Brito ◽  
Plínio Luna ◽  
Mayara Campêlo ◽  
Lívia Shirahige ◽  
...  

Background: Repetitive transcranial magnetic stimulation (rTMS) has been applied for modulating cortical excitability and treating spasticity in neurological lesions. However, it is unclear which rTMS frequency is most effective in modulating cortical and spinal excitability in incomplete spinal cord injury (SCI). Objective: To evaluate electrophysiological and clinical repercussions of rTMS compared to sham stimulation when applied to the primary motor cortex (M1) in individuals with incomplete SCI. Methods: A total of 11 subjects (35±12 years) underwent three experimental sessions of rTMS (10 Hz, 1 Hz and sham stimulation) in a randomized order at 90%intensity of the resting motor threshold and interspersed by a seven-day interval between sessions. The following outcome measures were evaluated: M1 and spinal cord excitability and spasticity in the moments before (baseline), immediately after (T0), 30 (T30) and 60 (T60) minutes after rTMS. M1 excitability was obtained through the motor evoked potential (MEP); spinal cord excitability by the Hoffman reflex (H-reflex) and homosynaptic depression (HD); and spasticity by the modified Ashworth scale (MAS). Results: A significant increase in cortical excitability was observed in subjects submitted to 10 Hz rTMS at the T0 moment when compared to sham stimulation (p = 0.008); this increase was also significant at T0 (p = 0.009), T30 (p = 0.005) and T60 (p = 0.005) moments when compared to the baseline condition. No significant differences were observed after the 10 Hz rTMS on spinal excitability or on spasticity. No inter-group differences were detected, or in the time after application of 1 Hz rTMS, or after sham stimulation for any of the assessed outcomes. Conclusions: High-frequency rTMS applied to M1 was able to promote increased cortical excitability in individuals with incomplete SCI for at least 60 minutes; however, it did not modify spinal excitability or spasticity.


2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Patricio O’Donnell ◽  
Francis M. Dijkstra ◽  
Ugur Damar ◽  
Lei Quanhong ◽  
Annika A. de Goede ◽  
...  

AbstractTAK-653 is a novel α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR)-positive allosteric modulator being developed as a potential therapeutic for major depressive disorder (MDD). Currently, there are no translational biomarkers that evaluate physiological responses to the activation of glutamatergic brain circuits available. Here, we tested whether noninvasive neurostimulation, specifically single-pulse or paired-pulse motor cortex transcranial magnetic stimulation (spTMS and ppTMS, respectively), coupled with measures of evoked motor response captures the pharmacodynamic effects of TAK-653 in rats and healthy humans. In the rat study, five escalating TAK-653 doses (0.1–50 mg/kg) or vehicle were administered to 31 adult male rats, while measures of cortical excitability were obtained by spTMS coupled with mechanomyography. Twenty additional rats were used to measure brain and plasma TAK-653 concentrations. The human study was conducted in 24 healthy volunteers (23 males, 1 female) to assess the impact on cortical excitability of 0.5 and 6 mg TAK-653 compared with placebo, measured by spTMS and ppTMS coupled with electromyography in a double-blind crossover design. Plasma TAK-653 levels were also measured. TAK-653 increased both the mechanomyographic response to spTMS in rats and the amplitude of motor-evoked potentials in humans at doses yielding similar plasma concentrations. TAK-653 did not affect resting motor threshold or paired-pulse responses in humans. This is the first report of a translational functional biomarker for AMPA receptor potentiation and indicates that TMS may be a useful translational platform to assess the pharmacodynamic profile of glutamate receptor modulators.


2020 ◽  
Vol 147 ◽  
pp. 107581
Author(s):  
Olga Lucia Gamboa Arana ◽  
Hannah Palmer ◽  
Moritz Dannhauer ◽  
Connor Hile ◽  
Sicong Liu ◽  
...  

2014 ◽  
Vol 7 (2) ◽  
pp. 275-280 ◽  
Author(s):  
Takahiro Kimura ◽  
Katsuya Ogata ◽  
Hisato Nakazono ◽  
Shozo Tobimatsu

Sign in / Sign up

Export Citation Format

Share Document